Ditchcarbon
  • Contact
  1. Organizations
  2. Krka
Public Profile
Pharmaceutical Preparation Manufacturing
SI
updated 23 days ago

Krka

Company website

Krka, d.d., a prominent pharmaceutical company headquartered in Slovenia (SI), has established itself as a leader in the global healthcare industry since its founding in 1946. With a strong presence in Europe and beyond, Krka focuses on the development, production, and marketing of prescription pharmaceuticals, over-the-counter products, and animal health medications. Renowned for its commitment to quality and innovation, Krka offers a diverse range of products, including generic medicines and proprietary brands, which are distinguished by their efficacy and affordability. The company has achieved significant milestones, including numerous awards for its research and development efforts, solidifying its position in the competitive pharmaceutical landscape. With a robust market presence and a dedication to sustainability, Krka continues to contribute to the advancement of healthcare worldwide.

DitchCarbon Score

How does Krka's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

33

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Krka's score of 33 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.

55%

Let us know if this data was useful to you

Krka's reported carbon emissions

In 2024, Krka, headquartered in Slovenia (SI), reported total carbon emissions of approximately 598,682,000 kg CO2e. This figure includes 56,868,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 17,133,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, heat, and steam. Notably, the majority of their emissions, about 524,681,000 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions in the value chain. In comparison, Krka's emissions for 2023 were approximately 74,018,000 kg CO2e for Scope 1 and 2 combined, with no Scope 3 data disclosed for that year. The trend shows a slight decrease in Scope 1 emissions from 61,592,000 kg CO2e in 2022 to 59,029,000 kg CO2e in 2023, indicating ongoing efforts to manage their carbon footprint. Despite these figures, Krka has not set specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges. The company has not disclosed any significant climate commitments or reduction initiatives, which places them in a context where many industry peers are actively pursuing measurable sustainability goals. Overall, while Krka has made strides in tracking and reporting emissions, the absence of formal reduction targets suggests an opportunity for enhanced climate action in alignment with global sustainability efforts.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201920202021202220232024
Scope 1
66,245,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
-
-
00,000,000
00,000,000
00,000,000
00,000,000
Scope 3
-
-
-
-
-
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Krka's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Krka is in SI, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Krka is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Adcock Ingram Holdings Limited

ZA
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Zentiva N.V.

NL
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Pfizer

US
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 12 days ago

Hikma Pharmaceuticals

GB
•
Pharmaceutical Preparation Manufacturing
Updated about 3 hours ago

Lek d. d.

SI
•
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251028.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy